Given Imaging, Olympus settle video pill row:
This article was originally published in Clinica
Executive Summary
Endoscopy rivals Given Imaging and Olympus have settled a patent litigation suit in the US concerning the companies' pill-sized diagnostic cameras. The two firms signed a term sheet for the settlement of the litigation which will see Yoqneam, Israel-based Given receive a payment of $2.33m. All past legal action between the two firms has been dropped and the companies agreed not to sue over devices that are currently available. This settlement sees both parties gain a cross-licence under existing and future patents for any future capsule endoscopy products, which may include the payment of royalties. Both companies have also agreed to co-operate in future joint marketing development projects. Given originally filed a patent litigation lawsuit against Olympus in October 2006, not long after Olympus launched its Endo Capsule small bowel visualisation device in Europe.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.